Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arsenicals | 1 | 2022 | 124 | 0.800 |
Why?
|
Arsenic | 1 | 2022 | 328 | 0.660 |
Why?
|
Antioxidants | 1 | 2023 | 1659 | 0.510 |
Why?
|
Cardiology | 2 | 2023 | 1668 | 0.490 |
Why?
|
Sex Characteristics | 3 | 2024 | 2585 | 0.450 |
Why?
|
Acute Coronary Syndrome | 2 | 2023 | 2337 | 0.430 |
Why?
|
Atherosclerosis | 4 | 2024 | 3444 | 0.430 |
Why?
|
Mesenchymal Stem Cells | 1 | 2023 | 1632 | 0.420 |
Why?
|
Myocardial Infarction | 3 | 2024 | 11718 | 0.410 |
Why?
|
Cell Polarity | 4 | 2018 | 645 | 0.390 |
Why?
|
Coronary Artery Disease | 4 | 2023 | 6486 | 0.380 |
Why?
|
Critical Care | 1 | 2023 | 2647 | 0.380 |
Why?
|
Intensive Care Units | 1 | 2023 | 3680 | 0.360 |
Why?
|
Cardiovascular Diseases | 7 | 2024 | 15160 | 0.340 |
Why?
|
Students, Medical | 1 | 2022 | 1862 | 0.340 |
Why?
|
Patient Readmission | 1 | 2023 | 3116 | 0.330 |
Why?
|
Heart Failure | 3 | 2023 | 10895 | 0.240 |
Why?
|
Coronary Care Units | 1 | 2023 | 214 | 0.210 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2023 | 379 | 0.180 |
Why?
|
Mental Disorders | 1 | 2019 | 6598 | 0.170 |
Why?
|
Calciphylaxis | 1 | 2021 | 124 | 0.170 |
Why?
|
Risk Factors | 8 | 2024 | 72296 | 0.160 |
Why?
|
Shock, Cardiogenic | 1 | 2023 | 688 | 0.160 |
Why?
|
Intercellular Junctions | 1 | 2018 | 203 | 0.160 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2023 | 838 | 0.150 |
Why?
|
Mentors | 1 | 2022 | 631 | 0.150 |
Why?
|
Protein Kinase C | 2 | 2018 | 1227 | 0.150 |
Why?
|
Career Choice | 1 | 2022 | 744 | 0.140 |
Why?
|
Anti-Infective Agents | 1 | 2023 | 974 | 0.140 |
Why?
|
Chest Pain | 1 | 2023 | 1114 | 0.130 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2023 | 1677 | 0.130 |
Why?
|
Myocardial Ischemia | 2 | 2023 | 2148 | 0.130 |
Why?
|
Humans | 24 | 2024 | 744366 | 0.120 |
Why?
|
Coronary Angiography | 2 | 2023 | 4576 | 0.120 |
Why?
|
Cardiovascular Agents | 1 | 2021 | 850 | 0.120 |
Why?
|
Dyslipidemias | 1 | 2021 | 849 | 0.120 |
Why?
|
Up-Regulation | 1 | 2023 | 4222 | 0.120 |
Why?
|
Arrhythmias, Cardiac | 1 | 2023 | 2269 | 0.110 |
Why?
|
Hemodynamics | 1 | 2023 | 4196 | 0.110 |
Why?
|
Anticholesteremic Agents | 1 | 2020 | 979 | 0.110 |
Why?
|
Hospital Mortality | 2 | 2024 | 5316 | 0.110 |
Why?
|
Quality of Life | 2 | 2022 | 12802 | 0.090 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2021 | 3255 | 0.090 |
Why?
|
Comorbidity | 1 | 2023 | 10388 | 0.080 |
Why?
|
Diagnostic Imaging | 1 | 2023 | 3508 | 0.080 |
Why?
|
Heart Diseases | 1 | 2021 | 2789 | 0.080 |
Why?
|
Prognosis | 3 | 2023 | 29060 | 0.080 |
Why?
|
Kidney Failure, Chronic | 1 | 2021 | 2535 | 0.080 |
Why?
|
Sex Factors | 1 | 2022 | 10400 | 0.080 |
Why?
|
Rotation | 2 | 2018 | 523 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2018 | 3690 | 0.070 |
Why?
|
Female | 10 | 2024 | 380193 | 0.070 |
Why?
|
Cell Nucleus | 1 | 2015 | 2969 | 0.070 |
Why?
|
Prevalence | 2 | 2022 | 15221 | 0.070 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7182 | 0.070 |
Why?
|
Heart | 1 | 2018 | 4464 | 0.060 |
Why?
|
Signal Transduction | 3 | 2023 | 23404 | 0.060 |
Why?
|
Hospitalization | 2 | 2023 | 10259 | 0.060 |
Why?
|
Male | 8 | 2024 | 350115 | 0.050 |
Why?
|
Lactates | 1 | 2023 | 432 | 0.050 |
Why?
|
Dogs | 2 | 2018 | 3912 | 0.050 |
Why?
|
Tachycardia, Sinus | 1 | 2021 | 42 | 0.050 |
Why?
|
Apolipoproteins | 1 | 2023 | 317 | 0.050 |
Why?
|
Vascular Resistance | 1 | 2023 | 936 | 0.050 |
Why?
|
Pregnancy | 1 | 2022 | 29144 | 0.040 |
Why?
|
Lipoprotein(a) | 1 | 2024 | 435 | 0.040 |
Why?
|
Stroke Volume | 2 | 2023 | 5006 | 0.040 |
Why?
|
Myosin Type II | 1 | 2018 | 68 | 0.040 |
Why?
|
Avian Proteins | 1 | 2018 | 80 | 0.040 |
Why?
|
American Heart Association | 1 | 2023 | 1057 | 0.040 |
Why?
|
Lactams | 1 | 2018 | 156 | 0.040 |
Why?
|
Microcirculation | 1 | 2022 | 1287 | 0.040 |
Why?
|
Biophysical Phenomena | 1 | 2018 | 327 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 1 | 2023 | 1877 | 0.040 |
Why?
|
Cell Shape | 1 | 2018 | 375 | 0.040 |
Why?
|
Arteries | 1 | 2022 | 1119 | 0.040 |
Why?
|
Organogenesis | 1 | 2018 | 222 | 0.040 |
Why?
|
Golgi Apparatus | 1 | 2018 | 410 | 0.040 |
Why?
|
Animals | 4 | 2023 | 168768 | 0.040 |
Why?
|
Chick Embryo | 1 | 2018 | 982 | 0.040 |
Why?
|
Cholesterol, HDL | 1 | 2023 | 1813 | 0.040 |
Why?
|
Permeability | 1 | 2018 | 738 | 0.040 |
Why?
|
Mice | 1 | 2023 | 81201 | 0.030 |
Why?
|
Drug Interactions | 1 | 2020 | 1460 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2018 | 1341 | 0.030 |
Why?
|
Electric Impedance | 1 | 2018 | 729 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 2024 | 2288 | 0.030 |
Why?
|
Body Patterning | 1 | 2018 | 626 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 16715 | 0.030 |
Why?
|
Cadherins | 1 | 2018 | 907 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2023 | 2355 | 0.030 |
Why?
|
Aged | 2 | 2023 | 163288 | 0.030 |
Why?
|
Ischemia | 1 | 2022 | 1907 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2018 | 3702 | 0.030 |
Why?
|
Patient Care Team | 1 | 2023 | 2531 | 0.020 |
Why?
|
Adult | 2 | 2024 | 214052 | 0.020 |
Why?
|
Cholesterol | 1 | 2020 | 2919 | 0.020 |
Why?
|
Societies, Medical | 1 | 2023 | 3743 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1678 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2023 | 3666 | 0.020 |
Why?
|
Lipids | 1 | 2021 | 3307 | 0.020 |
Why?
|
Indoles | 1 | 2018 | 1839 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2018 | 1629 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2504 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6755 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2018 | 2938 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5218 | 0.020 |
Why?
|
Pain | 1 | 2021 | 4988 | 0.020 |
Why?
|
Myocardium | 1 | 2018 | 4772 | 0.020 |
Why?
|
United States | 2 | 2024 | 69872 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 21748 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 19905 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4042 | 0.020 |
Why?
|
Anti-HIV Agents | 1 | 2020 | 4255 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9955 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 23336 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9584 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 13882 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2023 | 57776 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2024 | 63107 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53290 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2024 | 77460 | 0.010 |
Why?
|
Middle Aged | 1 | 2023 | 213390 | 0.010 |
Why?
|
Concepts
(123)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(39)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_